New genetic test could predict oesophageal cancer eight years earlier. Credit: Cancer Research UK.

Researchers from the University of Cambridge in the UK have developed a new genetic test that may help diagnose oesophageal cancer up to eight years before symptoms appear.

Upon analysis of tissue samples from patients with Barrett’s oesophagus, the researchers retrospectively identified predictive genetic markers in 94% of people who later went on to develop early signs of the disease.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The makers were detected in samples obtained during endoscopies for Barrett’s oesophagus over 15 years, several years before symptoms appeared.

To develop the test, researchers compared markers of 45 patients who developed early signs of the cancer with 45 of those who did not.

Designed to closely monitor early signs of disease development in people with high-risk genetic patterns, the test is intended to enable effective treatment by diagnosing the cancer early.

The test could also potentially decrease the number of endoscopies that majority of people at low risk had to undergo for the detection of oesophageal cancer.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
“The test is expected to help in better understanding of the disease, predict its development and aid in the development of new treatments.”

University of Cambridge MRC Cancer Unit researcher professor Rebecca Fitzgerald said: “Many people with oesophageal cancer are diagnosed when their disease has already spread and is harder to treat.

“Testing for these new markers during regular checks could help identify people who have a high chance of developing oesophageal cancer.”

The researchers intend to evaluate the test in clinical trials to determine its ability for early diagnosis of the cancer.

In addition to identification, the test is expected to help in better understanding of the disease, predict its development and aid in the development of new treatments.